1. No category

Investor Fact Sheet
May 2015
A pharmacy
innovation
company
CVS Health is a pharmacy innovation
company helping people on their path
to better health. Through our 7,800
retail pharmacies, nearly 1,000 walk-in
medical clinics, a leading pharmacy
benefits manager with approximately
71 million plan members, and expanding specialty pharmacy services, we
enable people, businesses and communities to manage health in more
affordable, effective ways. This unique
integrated model increases access
to quality care, delivers better health
outcomes and lowers overall health
care costs.
Stock Highlights as of 5/4/15
Ticker symbol largest U.S.
pharmacy
based on total
prescription revenue
1.7 billion
prescriptions filled
or managed
Nearly
220,000
colleagues
across 45 states
Stock price $100.16
Shares outstanding
~71 million
~1,000
retail pharmacies
PBM plan members
walk-in medical
clinics
1.1 billion
Market cap $113.38 billion
52-week range $74.64 - $105.46
Adj. earnings per share* (TTM)
$4.34
Forward price/earnings ratio
18.70
Dividend per share (TTM) $1.25
Dividend yield
1.4%
Financial
Highlights
~7,800
CVS
as of 3/31/15, in billions
Net revenues (TTM)
$143.0
Operating profit (TTM)
Free cash flow (TTM)
†
$8.9
$7.3
Total assets
$73.9
Long-term debt
$11.7
Shareholders’ equity
$37.0
* Adjusted earnings per share (EPS) is defined as income before income tax
provision plus amortization, less adjusted income tax provision and other,
which is comprised of earnings allocated to participating securities, divided
by the weighted average diluted shares outstanding.
Includes a $521 million loss on early extinguishment of debt (approximately
$0.27 per diluted share).
† Free
#
12
74
12
on Fortune 500
list
straight quarters
of dividends paid
consecutive years of
dividend increases
cash flow is defined as net cash provided by operating activities less
net additions to properties and equipment (i.e., additions to property and
equipment plus proceeds from sale-leaseback transactions).
Please visit investors.cvshealth.com
to learn more.
Investor Fact Sheet May 2015
Visit investors.cvshealth.com to learn more.
Substantial scale across the pharmacy and health care spectrum
Retail
Pharmacy
Rx Benefits
Management
Specialty
Pharmacy
Retail
Clinics
Front Store
(Health OTC)
Total market
3.9 billion scripts
Total market
4.3 billion scripts
$86 billion market*
$20 billion market
$60 billion market
25% share
1.5% share
10% share
21% share
25% share
†
Market share data as of December 2014.
* Addressable specialty market currently excludes infused oncology.
† MinuteClinic addressable market reflects outpatient and emergency department visits for the ten diagnoses most commonly seen in retail clinics. Sources: National Center for Health Statistics; 2009 Rand study.
Adjusted EPS from
continuing operations
Net revenue
in billions of dollars
107.1
123.1 126.8
139.4
143.0
in dollars
4.00
2.80
Annual dividend
in dollars per common share
1.25
4.34
4.22
1.10
.90
3.26
.50
11
12
13 14 15 TTM
11
12
13
14 $80
$60
15 TTM
11
.65
12
13 14 15 TTM
Focus on enhancing shareholder value
Driving productive
long-term growth
Generating significant
free cash flow
Optimizing capital
allocation
since 2010...
since 2010...
since 2010...
~$29 billion
70%
increased dividend
payout ratio from
$1.3 billion
approximately
in PBM net new business
~600
new retail stores
increase in cash from
operations
of excess retail
inventory removed
For further information:
Investor Relations
Transfer Agent
CVS Health Corporation
One CVS Drive
Woonsocket, Rhode Island 02895
Wells Fargo Shareowner Services
P.O. Box 64874
St. Paul, Minnesota 55164-0874
800-201-0938
877-287-7526
[email protected]
[email protected]
14% to 29%
$17 billion
in share repurchases